ES517062A0 - Un metodo para la preparacion de antraniloiloxialcanoatos. - Google Patents
Un metodo para la preparacion de antraniloiloxialcanoatos.Info
- Publication number
- ES517062A0 ES517062A0 ES517062A ES517062A ES517062A0 ES 517062 A0 ES517062 A0 ES 517062A0 ES 517062 A ES517062 A ES 517062A ES 517062 A ES517062 A ES 517062A ES 517062 A0 ES517062 A0 ES 517062A0
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- phenethyl
- preparation
- phenyl
- antraniloiloxialcanoatos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 4-nitro-phenethyl Chemical group 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000005936 piperidyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Biological Depolymerization Polymers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8134398 | 1981-11-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8404685A1 ES8404685A1 (es) | 1984-05-16 |
| ES517062A0 true ES517062A0 (es) | 1984-05-16 |
Family
ID=10525904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES517062A Granted ES517062A0 (es) | 1981-11-14 | 1982-11-03 | Un metodo para la preparacion de antraniloiloxialcanoatos. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4482561A (es) |
| EP (1) | EP0079740B1 (es) |
| JP (1) | JPS58135882A (es) |
| AT (1) | ATE16490T1 (es) |
| AU (1) | AU9045382A (es) |
| CA (1) | CA1193260A (es) |
| DE (1) | DE3242196A1 (es) |
| DK (1) | DK485282A (es) |
| ES (1) | ES517062A0 (es) |
| FI (1) | FI823723L (es) |
| GR (1) | GR77367B (es) |
| HU (1) | HU188224B (es) |
| IL (1) | IL67194A (es) |
| IT (1) | IT1196425B (es) |
| NL (1) | NL8204384A (es) |
| NO (1) | NO823659L (es) |
| NZ (1) | NZ202320A (es) |
| PT (1) | PT75834B (es) |
| ZA (1) | ZA828234B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3742580C1 (de) * | 1987-12-16 | 1989-05-11 | Schaper & Bruemmer Gmbh | Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE589546A (es) * | 1959-04-15 | |||
| FR6103M (es) * | 1967-02-22 | 1968-06-10 | ||
| FR6195M (es) * | 1967-04-11 | 1968-07-22 | ||
| FR2434808A1 (fr) * | 1978-09-01 | 1980-03-28 | Science Union & Cie | Nouveaux esters du methyl-1 piperidinol-4, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| FR2467846A1 (fr) * | 1979-10-22 | 1981-04-30 | Dufour J C | Nouveaux b hydroxy esters de piperidyle |
-
1982
- 1982-10-29 NZ NZ202320A patent/NZ202320A/en unknown
- 1982-11-01 FI FI823723A patent/FI823723L/fi not_active Application Discontinuation
- 1982-11-02 DK DK485282A patent/DK485282A/da not_active Application Discontinuation
- 1982-11-03 NO NO823659A patent/NO823659L/no unknown
- 1982-11-03 ES ES517062A patent/ES517062A0/es active Granted
- 1982-11-04 GR GR69725A patent/GR77367B/el unknown
- 1982-11-08 EP EP82305928A patent/EP0079740B1/en not_active Expired
- 1982-11-08 IL IL67194A patent/IL67194A/xx unknown
- 1982-11-08 AT AT82305928T patent/ATE16490T1/de active
- 1982-11-10 JP JP57198314A patent/JPS58135882A/ja active Pending
- 1982-11-10 ZA ZA828234A patent/ZA828234B/xx unknown
- 1982-11-11 PT PT75834A patent/PT75834B/pt unknown
- 1982-11-11 IT IT24204/82A patent/IT1196425B/it active
- 1982-11-12 CA CA000415439A patent/CA1193260A/en not_active Expired
- 1982-11-12 HU HU823650A patent/HU188224B/hu unknown
- 1982-11-12 NL NL8204384A patent/NL8204384A/nl not_active Application Discontinuation
- 1982-11-12 US US06/441,093 patent/US4482561A/en not_active Expired - Fee Related
- 1982-11-12 AU AU90453/82A patent/AU9045382A/en not_active Abandoned
- 1982-11-15 DE DE19823242196 patent/DE3242196A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ZA828234B (en) | 1983-09-28 |
| FI823723L (fi) | 1983-05-15 |
| US4482561A (en) | 1984-11-13 |
| IL67194A (en) | 1986-04-29 |
| DK485282A (da) | 1983-05-15 |
| NO823659L (no) | 1983-05-16 |
| EP0079740A1 (en) | 1983-05-25 |
| JPS58135882A (ja) | 1983-08-12 |
| GR77367B (es) | 1984-09-11 |
| FI823723A0 (fi) | 1982-11-01 |
| NZ202320A (en) | 1985-05-31 |
| NL8204384A (nl) | 1983-06-01 |
| AU9045382A (en) | 1983-05-19 |
| IL67194A0 (en) | 1983-03-31 |
| EP0079740B1 (en) | 1985-11-13 |
| IT8224204A0 (it) | 1982-11-11 |
| ATE16490T1 (de) | 1985-11-15 |
| IT1196425B (it) | 1988-11-16 |
| DE3242196A1 (de) | 1983-05-26 |
| ES8404685A1 (es) | 1984-05-16 |
| PT75834A (en) | 1982-12-01 |
| PT75834B (en) | 1985-11-12 |
| HU188224B (en) | 1986-03-28 |
| CA1193260A (en) | 1985-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2031821T3 (es) | Procedimiento para preparar derivados de 4(4-oxo-1,4-dihidropiridin-1-il)fenilo. | |
| AR021355A1 (es) | Derivados de quinolina. procedimiento para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de unmedicamento | |
| LU90410I2 (fr) | Milnacipran (chlorhydrate) | |
| DK0464465T3 (da) | Substituerede aminoalkylbiphenylderivater, antimykotiske præparater indeholdende disse derivater og mellemprodukter til fremstilling deraf | |
| DK188288D0 (da) | 1-phenyl-3-naphthalenyloxypropanaminer, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske midler indeholdende disse | |
| DK234388D0 (da) | 1,4-dihydropyridin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til deres fremstilling af laegemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling | |
| DK0583485T3 (da) | Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger | |
| EA200200489A1 (ru) | Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции | |
| ES543592A0 (es) | Procedimiento para preparar nuevas pirrolidinonas substitui-das | |
| DK0902684T3 (da) | Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler | |
| DK0461958T3 (da) | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien | |
| ES517062A0 (es) | Un metodo para la preparacion de antraniloiloxialcanoatos. | |
| DK0648202T3 (da) | Substituerede (arylalkylaminobenzyl)aminopropanamidderivater, fremstilling deraf og anvendelse som anti-epileptiske, neurobeskyttende og antidepressive midler | |
| ES2165410T3 (es) | Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| DK163783D0 (da) | Fremgangsmade til fremstilling af imidazolinderivater | |
| DK156396C (da) | 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse | |
| PT84161B (pt) | Processo para a preparacao de derivados de 3-acilaminometil-imidazo-{1,2-a}-piridinas e de composicoes farmaceuticas que os contem | |
| DK158729C (da) | N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat | |
| DK356287A (da) | 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse | |
| SE8500451D0 (sv) | N-substituted amino propane sulfonic acid derivatives | |
| BR9902841A (pt) | Compostos de 8h-tieno-{2,3-b}pirrolizin-8-ona, processo para suas preparações e composições farmacêuticas contendo os mesmos | |
| ES527550A0 (es) | Procedimiento para la preparacion de derivados de acridanona | |
| NO850244L (no) | Oksysalicylamidoderivater og fremgangsmaate for deres fremstilling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20041004 |